Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -65.20% is 17% above its 5-year average of -78.42%, near the high end of its 5-year range (-157.02%–-47.32%).
As of the fiscal period ended Tuesday, June 30, 2026. 3.07% below its 12-month average of -63.26%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -65.20%.
RETURN ON INVESTED CAPITAL (ROIC)
-65.20%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-63.26%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-85.65%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-78.42%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-61.34%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-56.03%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-3.07%
CURRENT VS 3Y AVG
+23.88%
CURRENT VS 5Y AVG
+16.85%
CURRENT VS 10Y AVG
-6.29%
CURRENT VS 15Y AVG
-16.37%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-82.92%
vs the sector median at left
Talphera, Inc.
Market Cap
$57.61M
Return on Invested Capital (ROIC)
-65.20%
TTM Avg
-63.26%
3Y Avg
-85.65%
5Y Avg
-78.42%
Market Cap
$57.76M
Return on Invested Capital (ROIC)
-43.97%
TTM Avg
-40.46%
3Y Avg
-48.41%
5Y Avg
-43.33%
Market Cap
$57.01M
Return on Invested Capital (ROIC)
-136.77%
TTM Avg
-80.48%
3Y Avg
-75.99%
5Y Avg
-77.22%
Market Cap
$56.98M
Return on Invested Capital (ROIC)
-68.91%
TTM Avg
-68.91%
3Y Avg
-68.91%
5Y Avg
-118.87%
Market Cap
$58.43M
Return on Invested Capital (ROIC)
-79.68%
TTM Avg
-67.52%
3Y Avg
-59.81%
5Y Avg
-47.97%
Market Cap
$58.94M
Return on Invested Capital (ROIC)
-604.20%
TTM Avg
-195.52%
3Y Avg
-273.84%
5Y Avg
-208.65%
Market Cap
$58.44M
Return on Invested Capital (ROIC)
-3699.99%
TTM Avg
-104.88%
3Y Avg
-89.50%
5Y Avg
-74.29%
Market Cap
$59.18M
Return on Invested Capital (ROIC)
-26.13%
TTM Avg
-90.47%
3Y Avg
-104.07%
5Y Avg
-130.48%
Market Cap
$55.25M
Return on Invested Capital (ROIC)
-63.52%
TTM Avg
-64.57%
3Y Avg
-49.25%
5Y Avg
-45.21%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Talphera, Inc. (TLPH) | $57.61M | -65.20% | -63.26% | -85.65% | -78.42% |
| Boundless Bio, Inc. (BOLD)vs › | $57.76M | -43.97% | -40.46% | -48.41% | -43.33% |
| Connect Biopharma Holdings Limited (CNTB)vs › | $57.01M | -136.77% | -80.48% | -75.99% | -77.22% |
| OKYO Pharma Limited (OKYO)vs › | $56.98M | -68.91% | -68.91% | -68.91% | -118.87% |
| Adicet Bio, Inc. (ACET)vs › | $58.43M | -79.68% | -67.52% | -59.81% | -47.97% |
| MiNK Therapeutics, Inc. (INKT)vs › | $58.94M | -604.20% | -195.52% | -273.84% | -208.65% |
| PDS Biotechnology Corporation (PDSB)vs › | $58.44M | -3699.99% | -104.88% | -89.50% | -74.29% |
| Xilio Therapeutics, Inc. (XLO)vs › | $59.18M | -26.13% | -90.47% | -104.07% | -130.48% |
| Aldeyra The (ALDX)vs › | $55.25M | -63.52% | -64.57% | -49.25% | -45.21% |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.02M | -1235.48% | -801.38% | -433.95% | -312.84% |
ROIC
-65.2%
ROE
-104.7%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -65.20% |
| 2026-03-31 | -55.55% |
| 2025-12-31 | -52.04% |
| 2025-09-30 | -47.32% |
| 2025-06-30 | -96.18% |
| 2025-03-31 | -107.11% |
| 2024-12-31 | -97.84% |
| 2024-09-30 | -90.61% |
| 2024-06-30 | -74.59% |
| 2024-03-31 | -62.13% |
| 2023-12-31 | -106.33% |
| 2023-09-30 | -101.55% |
| 2023-06-30 | -157.02% |
| 2023-03-31 | -128.57% |
| 2022-12-31 | -65.28% |
| 2022-09-30 | -64.86% |
| 2022-06-30 | -62.93% |
| 2022-03-31 | -49.82% |
| 2021-12-31 | -52.75% |
| 2021-09-30 | -57.89% |
| 2021-06-30 | -51.17% |
| 2021-03-31 | -42.51% |
| 2020-12-31 | -71.37% |
| 2020-09-30 | -79.76% |
| 2020-06-30 | -85.58% |
| 2020-03-31 | -84.22% |
| 2019-12-31 | -65.52% |
| 2019-09-30 | -52.11% |
| 2019-06-30 | -43.05% |
| 2019-03-31 | -38.05% |
| 2018-12-31 | -31.45% |
| 2018-09-30 | -45.20% |
| 2018-06-30 | -53.55% |
| 2018-03-31 | -57.22% |
| 2017-12-31 | -55.08% |
| 2017-09-30 | -48.99% |
| 2017-06-30 | -51.26% |
| 2017-03-31 | -43.38% |
| 2016-12-31 | -34.19% |
| 2016-09-30 | -32.47% |
| 2016-06-30 | -16.17% |
| 2016-03-31 | -15.00% |
| 2015-12-31 | -16.04% |
| 2015-09-30 | -18.94% |
| 2015-06-30 | -59.59% |
| 2015-03-31 | -57.18% |
| 2014-12-31 | -47.33% |
| 2014-09-30 | -6.50% |
| 2014-06-30 | -9.73% |
| 2014-03-31 | -4.84% |
| 2013-12-31 | -6.46% |
| 2013-09-30 | -45.41% |
| 2013-06-30 | -94.50% |
| 2013-03-31 | -73.88% |
| 2012-12-31 | -51.56% |
| 2012-09-30 | -118.69% |
| 2012-06-30 | -74.90% |
| 2012-03-31 | -72.79% |
| 2011-12-31 | -52.59% |
| 2011-09-30 | -50.80% |
| 2011-06-30 | -36.56% |
| 2011-03-31 | -34.01% |
| 2010-12-31 | -224.59% |
| 2010-09-30 | -142.16% |
